Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF

Figures

• 

  Figure 1. Derivation of study population. COMBINE‐AF indicates a Collaboration Between Multiple Institutions to Better Investigate Non‐Vitamin K Antagonist Oral Anticoagulation Use in Atrial Fibrillation; and SE, systemic embolism.

• 

  Figure 2. Kaplan–Meier failure function for stroke/systemic embolism by CHA2DS2‐Vasc score. SE indicates systemic embolism.

• 

  Figure 3. Kaplan–Meier failure function by atrial fibrillation type and CHA2DS2‐VASc score strata. AF indicates atrial fibrillation.

• 

  Figure 4. Kaplan–Meier failure function for stroke/systemic embolism by CHA2DS2‐Vasc score <4/≥4 and by stroke history.